207305-48-4

Basic information

• Product Name: Carbamic acid, [(1S)-1-formyl-3-phenylpropyl]-, phenylmethyl ester
• CAS NO: 207305-48-4
• Molecular Formula: C18H19NO3
• Molecular Weight: 297.354
• Mol File: 207305-48-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S)-1-formyl-3-phenylpropyl]-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S)-1-formyl-3-phenylpropyl]-, phenylmethyl ester(207305-48-4)
• EPA Substance Registry System: Carbamic acid, [(1S)-1-formyl-3-phenylpropyl]-, phenylmethyl ester(207305-48-4)

Safety Data

• Hazardous Substances Data: 207305-48-4(Hazardous Substances Data)

Upstream product

• 943-73-7 D-homophenylalanine 
• 205983-74-0 phenylmethyl (2S)-[1-[[(methoxymethyl)amino]carbonyl]-3-phenylpropyl]carbamate 
• 83793-44-6 Z-homophenylalanine 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 611209-87-1 N-(benzyloxycarbonyl)-homo-L-phenylalaninol 

Downstream Products

• 218774-07-3 [(1S,2R)-2-(tert-Butyl-dimethyl-silanyloxy)-1-phenethyl-but-3-enyl]-carbamic acid benzyl ester 
• 218774-05-1 [(1S,2S)-2-(tert-Butyl-dimethyl-silanyloxy)-1-phenethyl-but-3-enyl]-carbamic acid benzyl ester 
• 218774-17-5 {(S)-1-[(S)-1-((R)-Oxiranecarbonyl)-3-phenyl-propylcarbamoyl]-2-phenyl-ethyl}-carbamic acid benzyl ester 
• 218774-11-9 {(S)-1-[(S)-1-((S)-Oxiranecarbonyl)-3-phenyl-propylcarbamoyl]-2-phenyl-ethyl}-carbamic acid benzyl ester 
• 611210-31-2 (2S)-N-[(1S)-1-(1,3-dioxolan-2-yl)-3-phenylpropyl]-2-hydroxy-4-methylpentanamide 
• 611210-35-6 (2S)-N-[(1S)-1-(1,3-dioxolan-2-yl)-3-phenylpropyl]-2-hydroxy-3-methylbutanamide 
• 611210-18-5 (1S)-1-(1,3-dioxolan-2-yl)-3-phenylpropan-1-amine 
• 611210-06-1 N-((1S)-1-(2,5-dioxolanyl)-3-phenylpropyl)(benzyloxy)formamide 

Relevant articles and documents

HYDROXYMORPHOLINONE DERIVATIVE AND MEDICINAL USE THEREOF

A compound represented by the following formula (I) wherein R1 and R2 are each a lower alkyl group optionally having substituents, which has a calpain inhibitory activity, or a salt thereof is provided.

Novel stereoselective syntheses of the fused benzazepine dopamine D1 antagonist (6as,13br)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5h-benzo[d]naphth[2,1-b] azepin-12-ol (sch 39166): 2. l-homophenylalanine-based syntheses

Two enantioselective syntheses of the fused benzazepine dopamine D1 antagonist (6aS,13bR)-11-chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b] azepin-12-ol (1) are described in which the starting material is (+)-L-homophenylalan